295 related articles for article (PubMed ID: 7723741)
41. Discovery of novel peptide/receptor interactions: identification of PHM-27 as a potent agonist of the human calcitonin receptor.
Ma JN; Currier EA; Essex A; Feddock M; Spalding TA; Nash NR; Brann MR; Burstein ES
Biochem Pharmacol; 2004 Apr; 67(7):1279-84. PubMed ID: 15013843
[TBL] [Abstract][Full Text] [Related]
42. Adenylate cyclase activation and competitive binding with renal tissue using synthetic eel calcitonin analog and its fragments.
Yamamoto I; Morita R; Fukunaga M; Dokoh S; Shigeno C; Torizuka K; Noda T
Endocrinology; 1981 Feb; 108(2):698-702. PubMed ID: 7449744
[TBL] [Abstract][Full Text] [Related]
43. Salmon calcitonin binding and stimulation of cyclic AMP generation in rat skeletal muscle.
Kenney MA; Moore CX; Pittner R; Beaumont K
Biochem Biophys Res Commun; 1993 Nov; 197(1):8-14. PubMed ID: 8250950
[TBL] [Abstract][Full Text] [Related]
44. 3,5 cyclic adenosine monophosphate mediates the salmon calcitonin-induced increase in hypothalamic tyrosine hydroxylase activity.
Arbogast LA; Shah GV; Voogt JL
Endocrinology; 1999 Jul; 140(7):3273-81. PubMed ID: 10385424
[TBL] [Abstract][Full Text] [Related]
45. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
D'Santos CS; Nicholson GC; Moseley JM; Evans T; Martin TJ; Kemp BE
Endocrinology; 1988 Sep; 123(3):1483-8. PubMed ID: 2841096
[TBL] [Abstract][Full Text] [Related]
46. Electrophoretic mobility and glycosylation characteristics of heterogeneously expressed calcitonin receptors.
Quiza M; Dowton M; Perry KJ; Sexton PM
Endocrinology; 1997 Feb; 138(2):530-9. PubMed ID: 9002982
[TBL] [Abstract][Full Text] [Related]
47. Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin.
Albrandt K; Mull E; Brady EM; Herich J; Moore CX; Beaumont K
FEBS Lett; 1993 Jul; 325(3):225-32. PubMed ID: 8391477
[TBL] [Abstract][Full Text] [Related]
48. Control of cyclic adenosine 3',5'-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase.
Nicholson GC; Moseley JM; Yates AJ; Martin TJ
Endocrinology; 1987 May; 120(5):1902-8. PubMed ID: 3032571
[TBL] [Abstract][Full Text] [Related]
49. Dual effects of calcitonin and calcitonin gene-related peptide on intracellular cyclic 3',5'-monophosphate in a human breast cancer cell line.
Barsony J; Marx SJ
Endocrinology; 1988 Apr; 122(4):1218-23. PubMed ID: 2831023
[TBL] [Abstract][Full Text] [Related]
50. Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line.
Hunt NH; Ellison M; Underwood JC; Martin TJ
Br J Cancer; 1977 Jun; 35(6):777-84. PubMed ID: 194616
[TBL] [Abstract][Full Text] [Related]
51. Action of calcitonin gene-related peptide at the calcitonin receptor of the T47D cell line.
Raue F; Schneider HG; Zink A; Ziegler R
Horm Metab Res; 1987 Nov; 19(11):563-4. PubMed ID: 2828211
[TBL] [Abstract][Full Text] [Related]
52. des-Ser2 salmon calcitonin: a biologically potent synthetic analog.
Schwartz KE; Orlowski RC; Marcus R
Endocrinology; 1981 Mar; 108(3):831-5. PubMed ID: 6257497
[TBL] [Abstract][Full Text] [Related]
53. Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line.
Findlay DM; deLuise M; Michelangeli VP; Ellison M; Martin TJ
Cancer Res; 1980 Apr; 40(4):1311-7. PubMed ID: 6244091
[TBL] [Abstract][Full Text] [Related]
54. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism.
Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
Endocrinology; 1996 Jan; 137(1):312-20. PubMed ID: 8536630
[TBL] [Abstract][Full Text] [Related]
55. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
Epand RM; Epand RF; Stafford AR; Orlowski RC
J Med Chem; 1988 Aug; 31(8):1595-8. PubMed ID: 3397998
[TBL] [Abstract][Full Text] [Related]
56. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt.
Kazantzis A; Waldner M; Taylor JW; Kapurniotu A
Eur J Biochem; 2002 Feb; 269(3):780-91. PubMed ID: 11846779
[TBL] [Abstract][Full Text] [Related]
57. Analogues of human calcitonin. V. Influence of basic amino acids in positions 11, 17 and 24 on hypocalcaemic activity in the rat.
Maier R; Brugger M; Brückner H; Kamber B; Riniker B; Rittel W
Acta Endocrinol (Copenh); 1977 May; 85(1):102-8. PubMed ID: 577069
[TBL] [Abstract][Full Text] [Related]
58. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
Endocrinology; 1996 Mar; 137(3):1042-8. PubMed ID: 8603572
[TBL] [Abstract][Full Text] [Related]
59. A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats.
Yates AJ; Gutierrez GE; Garrett IR; Mencel JJ; Nuss GW; Schreiber AB; Mundy GR
Endocrinology; 1990 Jun; 126(6):2845-9. PubMed ID: 2351097
[TBL] [Abstract][Full Text] [Related]
60. Protein kinase-C-induced down-regulation of calcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN cells.
Findlay DM; Michelangeli VP; Robinson PJ
Endocrinology; 1989 Nov; 125(5):2656-63. PubMed ID: 2551660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
